Abstract
Recombinant interleukin-2 (rIL-2) immunotherapy is limited by microvascular endothelial cell (EC)-targeted injury. The interaction between rIL-2-activated lymphoid cells and EC is a possible mechanism of this systemic toxicity. Taurine, a beta-amino acid, is known to have several physiologic actions, including the modulation of calcium homeostasis. The aims of this study were to analyze the effects of taurine on rIL-2-activated, lymphocyte-mediated EC and tumor cell cytotoxicity and to investigate the mechanisms of its action. IL-2-activated cytotoxicity, mediated by peripheral blood mononuclear cells, against susceptible tumor cell lines and against EC (fresh EC and an EC cell line) in the presence of taurine was assessed. The effects of taurine on lymphocyte [Ca2+]i were assessed by flow cytometry, and the effects of taurine on granzyme activity were assessed by spectrophotometry. The authors' findings indicated that the addition of taurine significantly reduced rIL-2-activated EC cytotoxicity mediated by natural killer cells, without reducing antitumor response. Taurine was also shown to reduce significantly EC lysis mediated by lymphokine-activated killer (LAK) cells, while also significantly increasing tumor cytotoxicity. ...Continue Reading
References
Jan 1, 1992·Advances in Experimental Medicine and Biology·M A BanksV Castranova
Jan 1, 1992·Physiological Reviews·R J Huxtable
Feb 1, 1992·American Heart Journal·J MileiA Boveris
Nov 1, 1991·Archives of Otolaryngology--head & Neck Surgery·B B BurkeyG T Wolf
Nov 1, 1991·Immunology Today·G Berke
Nov 15, 1991·Cancer·S FujitaV J Ferrans
Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
Mar 15, 1990·Mechanisms of Ageing and Development·S NishioA Aoike
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J R BenderE Engleman
Jul 1, 1989·The American Journal of the Medical Sciences·D E BechardF L Glauser
Dec 22, 1988·The New England Journal of Medicine·S A RosenbergC A Seipp
Mar 1, 1988·Immunological Reviews·J D YoungZ A Cohn
Sep 1, 1987·European Journal of Immunology·A M MiltenburgL C Paul
Dec 15, 1986·Cancer·M T LotzeS A Rosenberg
Dec 5, 1985·The New England Journal of Medicine·S A RosenbergJ T Vetto
Nov 1, 1973·The Journal of Clinical Investigation·E A JaffeC R Minick
Jun 1, 1982·The Journal of Experimental Medicine·E A GrimmS A Rosenberg
Mar 1, 1995·The Journal of Cell Biology·S PfauJ R Bender
Oct 1, 1993·American Journal of Respiratory Cell and Molecular Biology·M BédardM Denis
Apr 1, 1995·Cellular Immunology·H NagatakeY Kobayashi
Jan 27, 1995·Journal of Immunological Methods·B BrooksK P Windebank
Oct 1, 1994·The Journal of Experimental Medicine·J D BonnemaP J Leibson
Jan 1, 1993·International Immunology·H UmeharaE T Bloom
May 1, 1993·Cellular Immunology·M F RomanoS Formisano
Jul 1, 1993·Journal of Medical Microbiology·R Jakob
Sep 1, 1993·Metabolism: Clinical and Experimental·M IkebuchiY Shigeta
Mar 1, 1993·European Journal of Immunology·M V ClémentM Sasportes
Nov 1, 1996·Shock·J H WangD Bouchier-Hayes
Citations
Apr 14, 2009·International Immunopharmacology·Georgia Schuller-LevisEunkyue Park
Jan 19, 2005·Clinical and Experimental Immunology·S G MaherD M Toomey
May 31, 2006·Pediatrics International : Official Journal of the Japan Pediatric Society·Mehmet Ali ErgunNecat Imirzalioglu
Feb 16, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Eunkyue ParkGeorgia Schuller-Levis
Aug 17, 2016·Veterinary Microbiology·Bin DaiYulong Yin
Jan 1, 2012·Microbial Ecology in Health and Disease·Olav Albert Christophersen
Apr 18, 2006·Irish Journal of Medical Science·G C O'BrienH P Redmond
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·T MekhailR Bukowski
Sep 2, 2003·The Journal of Nutrition·Samira BoujendarBrigitte Reusens